GLP-1 agonists (Byetta, etc) are a good choice for weight loss in patients WITHOUT diabetes.

January 1

This isn’t completely true. GLP-1 agonists do result in short-term weight loss, but safety is a concern.

Alternative weight loss meds are tempting in light of all the cardiovascular and other concerns with antiobesity drugs.

GLP-1 agonists seem to cause weight loss by slowing gastric motility, increasing satiety, and suppressing appetite.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote